ConductScience.org, home

Paper24255575

Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment.

Zhang Y and 5 others. Chin J Cancer Res, 2013. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. Papers, record 24255575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24255575

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment.
PubMed
Journal
Chin J Cancer Res
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.39
iCite
Revised in PubMed
2022-03-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYanshan
2Yao YYunyi
3Wang HHuijuan
4Guo YYanqin
5Zhang HHui
6Chen LLiang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122286106Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.Cell Signal2012https://conductscience.org/library/papers/22286106PubMed
219525723Friend or foe? Resolving the impact of glial responses in glaucoma.J Glaucoma2009https://conductscience.org/library/papers/19525723PubMed
321480238Tumor microenvironment and progression.J Surg Oncol2011https://conductscience.org/library/papers/21480238PubMed
422510398Primary brain tumours in adults.Lancet2012https://conductscience.org/library/papers/22510398PubMed
522341931Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.Clin Neurol Neurosurg2012https://conductscience.org/library/papers/22341931PubMed
622440877Management of multifocal and multicentric gliomas.Neurosurg Clin N Am2012https://conductscience.org/library/papers/22440877PubMed
722420577Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.Clin Pharmacokinet2012https://conductscience.org/library/papers/22420577PubMed
822417747Antioxidant and bioenergetic coupling between neurons and astrocytes.Biochem J2012https://conductscience.org/library/papers/22417747PubMed
922537212Free radicals and antioxidants: updating a personal view.Nutr Rev2012https://conductscience.org/library/papers/22537212PubMed
1022549953Links between metabolism and cancer.Genes Dev2012https://conductscience.org/library/papers/22549953PubMed
1122440863Current surgical management of insular gliomas.Neurosurg Clin N Am2012https://conductscience.org/library/papers/22440863PubMed
1222499675Glial hemichannels and their involvement in aging and neurodegenerative diseases.Rev Neurosci2012https://conductscience.org/library/papers/22499675PubMed
1321036578The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials.Phytomedicine2011https://conductscience.org/library/papers/21036578PubMed
1422440866Characteristics and treatment of seizures in patients with high-grade glioma: a review.Neurosurg Clin N Am2012https://conductscience.org/library/papers/22440866PubMed
1520925470Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.Expert Rev Neurother2010https://conductscience.org/library/papers/20925470PubMed
1622192883Targeting the S and G2 checkpoint to treat cancer.Drug Discov Today2012https://conductscience.org/library/papers/22192883PubMed
1720378318Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.Phytomedicine2010https://conductscience.org/library/papers/20378318PubMed
1822190972Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Clin Dev Immunol2011https://conductscience.org/library/papers/22190972PubMed
1922493542Mouse models of pancreatic cancer.World J Gastroenterol2012https://conductscience.org/library/papers/22493542PubMed
2022549954Astrocytes and disease: a neurodevelopmental perspective.Genes Dev2012https://conductscience.org/library/papers/22549954PubMed

See all 22 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42925475Characterization of Anticancer Activities of Rhodiola rosea L. Extracts in Breast Tumor Cells: Phenotype Changes and Potential Mechanisms of Action.Cell Biochem Biophys2026https://conductscience.org/library/papers/42925475PubMed
42889017Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis.Front Oncol2026https://conductscience.org/library/papers/42889017PubMed
42720006Mechanistic Investigation of Salidroside Modulates Iron Overload to Mitigate Radiation-Induced Heart Disease.Cardiovasc Ther2026https://conductscience.org/library/papers/42720006PubMed
42018209Salidroside in heavy metal toxicity: a mechanistic review of antioxidant, anti-inflammatory, and anti-apoptotic pathways.Biometals2026https://conductscience.org/library/papers/42018209PubMed
41003973Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets.Inflammopharmacology2025https://conductscience.org/library/papers/41003973PubMed
40343296Salidroside impedes Ang II-infused myocardial fibrosis by activating the SIRT1-Nrf2 pathway.Iran J Basic Med Sci2025https://conductscience.org/library/papers/40343296PubMed
39636431Salidroside overcomes cisplatin resistance in ovarian cancer via the inhibition of CRNDE-mediated autophagy.Mol Cell Biochem2025https://conductscience.org/library/papers/39636431PubMed
38333759Salidroside alleviates LPS-induced liver injury and inflammation through SIRT1- NF-κB pathway and NLRP3 inflammasome.Iran J Basic Med Sci2024https://conductscience.org/library/papers/38333759PubMed
37920527Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway.Heliyon2023https://conductscience.org/library/papers/37920527PubMed
37423604Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway.Thorac Cancer2023https://conductscience.org/library/papers/37423604PubMed
37375742Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37375742PubMed
35695011Rhodiola rosea polysaccharides promote the proliferation of bone marrow haematopoietic progenitor cells and stromal cells in mice with aplastic anaemia.Pharm Biol2022https://conductscience.org/library/papers/35695011PubMed
34377008The Promoting Effect of Traumatic Brain Injury on the Incidence and Progression of Glioma: A Review of Clinical and Experimental Research.J Inflamm Res2021https://conductscience.org/library/papers/34377008PubMed
32587256Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.Cell Death Dis2020https://conductscience.org/library/papers/32587256PubMed
32560471Protective Evaluation of Compounds Extracted from Root of Rhodiola rosea L. against Methylglyoxal-Induced Toxicity in a Neuronal Cell Line.Molecules2020https://conductscience.org/library/papers/32560471PubMed
32144560Advances in Research on Anticancer Properties of Salidroside.Chin J Integr Med2021https://conductscience.org/library/papers/32144560PubMed
31637020The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports.Signal Transduct Target Ther2019https://conductscience.org/library/papers/31637020PubMed
31452742Cryptotanshinone inhibits lung cancer invasion via microRNA-133a/matrix metalloproteinase 14 regulation.Oncol Lett2019https://conductscience.org/library/papers/31452742PubMed
30393593Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention.Curr Pharmacol Rep2017https://conductscience.org/library/papers/30393593PubMed
29774132Natural products: a hope for glioblastoma patients.Oncotarget2018https://conductscience.org/library/papers/29774132PubMed

See all 24 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SOD16647PubTator's text mininghttps://conductscience.org/library/genes/6647

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24255575

GET https://conductscience.org/api/papers/v1/24255575/references?page=2